Concepedia

Rita Sulahian

RS

17

Publications

1.1K

Citations

17

H-Index

2004

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

The University of Texas Southwestern Medical Center

Broad Institute

Rita Sulahian is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingGene ExpressionCancer ResearchSystems BiologySignal TransductionGeneticsTumor BiologyCancer Biology

Publications per year

2004–2022

17

Publications

17

Differentiation-Specific Histone Modifications Reveal Dynamic Chromatin Interactions and Partners for the Intestinal Transcription Factor CDX2

Michael P. Verzi, Hyunjin Shin, Housheng Hansen He et al. · Developmental Cell · 2010 · 207 citations · Full text

Histone Modifications, Chromatin, Chromatin Structure +12

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

Belinda Wang, Elsa Krall, Andrew J. Aguirre et al. · Cell Reports · 2017 · 119 citations · Full text

Signal Transduction, Signaling Pathway, Genetics +6

Discovery of a selective inhibitor of doublecortin like kinase 1

Fleur M. Ferguson, Behnam Nabet, Srivatsan Raghavan et al. · Nature Chemical Biology · 2020 · 111 citations · Full text

Medicine, Receptor Tyrosine Kinase, Kinase 1 +5

Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers

Rita Sulahian, Jason J. Kwon, Katherine H. Walsh et al. · Cell Reports · 2019 · 90 citations · Full text

Synthetic Lethal Interaction, Shoc2 Depletion, Cancer Biology +17

An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer

Rita Sulahian, Fergal Casey, Jie Shen et al. · Oncogene · 2013 · 81 citations · Full text

Transcriptional Regulation, Systems Biology, Signaling Pathway +8

Rows per page

1–5 of 17